Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05723679 · ClinicalTrials.gov registry record · NA

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

A NA study of Obesity and Heart Failure With Preserved Ejection Fraction, sponsored by University of Texas Southwestern Medical Center.

Recruiting
Registry status
NA
Development phase
78
Enrollment target
1
Study location

NCT05723679 is a NA study of Obesity and Heart Failure With Preserved Ejection Fraction that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 78 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05723679, a NA study of Obesity and Heart Failure With Preserved Ejection Fraction, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.

RECRUITING
Registry status
NA
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The overall purpose of this study is to investigate whether pulmonary limitations that increase the oxygen (O2) cost of breathing impact dyspnea on exertion (DOE) and peak exercise capacity in patients with HFpEF and obesity. As per investigator's hypothesis, obesity is likely a significant contributor to DOE and exercise intolerance in patients with HFpEF.

Interventions

  • OTHER HeO2 gas mixture
  • OTHER Room air gas mixture

Study Locations (1)

Texas

  • UT Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2023-07-01
Est. Completion 2029-06-30
Phase NA

What the Registry Record Tells You About NCT05723679

The ClinicalTrials.gov registry entry for NCT05723679 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (90% lower). The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which HeO2 gas mixture is the first listed.

NCT05723679 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05723679 about?

NCT05723679 is a clinical study titled "Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF". The overall purpose of this study is to investigate whether pulmonary limitations that increase the oxygen (O2) cost of breathing impact dyspnea on exertion (DOE) and peak exercise capacity in patients with HFpEF and obesity. As per investigator's hypothesis, obesity is likely a significant contribu...

What is the current status of trial NCT05723679?

This trial is currently recruiting. It is a NA study. The enrollment target is 78 participants. The study started on 2023-07-01. Estimated completion is 2029-06-30.

What conditions does trial NCT05723679 study?

This clinical trial studies the following conditions: Obesity, Heart Failure With Preserved Ejection Fraction.

What interventions are being tested in trial NCT05723679?

The interventions under investigation include: HeO2 gas mixture (OTHER), Room air gas mixture (OTHER).

Who is sponsoring clinical trial NCT05723679?

This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05723679 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.